One obstacle to realizing the promise of viral vectors for vaccine delivery is pre-existing immunity to such vectors. An adroit application of structure-based design points to a way around that problem.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Roberts, D. M. et al. Nature 441, 239–243 (2006).
Casimiro, D. R. et al. J. Virol. 77, 7663–7668 (2003).
Santra, S. et al. J. Virol. 79, 6516–6522 (2005).
Bangari, D. S. & Mittal, S. K. Vaccine 24, 849–862 (2006).
Shiver, J. W. & Emini, E. A. Annu. Rev. Med. 55, 355–372 (2004).
Barouch, D. H. & Nabel, G. J. Hum. Gene Ther. 16, 149–156 (2005).
Sullivan, N. J. et al. Nature 424, 681–684 (2003).
Lemckert, A. A. et al. J. Virol. 79, 9694–9701 (2005).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mascola, J. Engineering immune evasion. Nature 441, 161 (2006). https://doi.org/10.1038/441161a
Published:
Issue date:
DOI: https://doi.org/10.1038/441161a
